Heidelberg Epignostix

Heidelberg Epignostix is focused on enhancing diagnostic accuracy and clinical care for cancer patients through innovative precision molecular diagnostics. Established in 2022, the startup specializes in developing software solutions for molecular tumor classification using DNA methylation profiling and machine learning, aiming to provide personalized treatment options for cancer patients. Their interdisciplinary team combines expertise from various fields to drive advancements in oncology and improve patient outcomes.